GLP-1 Side Effects Men Over 50 Should Actually Watch For

Disclosure: This post contains affiliate links. If you purchase through them, we may earn a commission at no extra cost to you. We only recommend products that meet our evidence standard.

Whether a GLP-1 works is only half the question. The other half is what it does to you on the way there.

So I went to the source: the FDA prescribing information for Wegovy (semaglutide) and Zepbound (tirzepatide), plus the FDA’s own mood review and the longest trial I could open.

What Are the Most Common GLP-1 Side Effects?

For Wegovy: nausea, then diarrhea, then vomiting and constipation (tied). These are the rates from the weight-loss trials, with placebo in parentheses:

• Wegovy: nausea 44% (16%), diarrhea 30% (16%), vomiting 24% (6%), constipation 24% (11%), abdominal pain 20% (10%).
• Zepbound, depending on dose: nausea 25% to 29% (8%), diarrhea 19% to 23% (8%), constipation 11% to 17% (5%), vomiting 8% to 13% (2%).

Headache, fatigue, heartburn, bloating and belching also run above placebo, at lower rates. Wegovy’s label also lists altered taste (1.7% versus 0.5% on placebo), and Zepbound’s lists dry mouth or dry throat (1% versus 0.1%).

One catch: these trials skewed female. Wegovy’s safety pool was 71% women and Zepbound’s was 37% men. Hair loss is where both labels split the numbers out by sex. On Zepbound it was 7.1% of women and 0.5% of men. On Wegovy it was 4% of women and 0.9% of men, against 2% and none on placebo. Both labels say hair loss was associated with weight reduction.

When Do GLP-1 Side Effects Start, and Do They Go Away?

They usually show up early and ease off. The Zepbound label says most nausea, vomiting and diarrhea happened during dose escalation and decreased over time.

That’s why both drugs start low and step up. Zepbound’s label raises the dose in steps at least four weeks apart, and Wegovy’s tells prescribers they can consider delaying a step by four weeks if a dose isn’t tolerated. How fast you climb is your prescriber’s decision.

The early weeks are also when people quit. Most Zepbound patients who stopped because of side effects did it in the first few months, mostly for GI reasons. On Wegovy, 6.8% stopped for adverse reactions, compared with 3.2% on placebo.

What Are the Serious Side Effects of GLP-1 Drugs?

Both labels carry the same boxed warning, plus a short list of less common problems worth knowing by name.

Thyroid C-cell tumors. Both drugs caused these tumors in rodents. Whether they do in humans is unknown. If you or a family member has had medullary thyroid carcinoma, or you have MEN 2, these drugs are off the table.

Pancreatitis. The warning sign is severe stomach pain that won’t go away, sometimes running through to your back.

Gallbladder disease. On Wegovy, gallstones were reported in 1.6% of patients against 0.7% on placebo. Fast weight loss raises that risk on its own, but the label says the gap held even after accounting for it. Zepbound’s label shows gallstones at 1.1% versus 1% and gallbladder inflammation at 0.7% versus 0.2%, tied to weight reduction.

Severe stomach problems. Both current labels warn that GI side effects are sometimes severe. In the weight-loss trials, severe GI reactions hit 4.1% of Wegovy injection patients versus 0.9% on placebo. Neither label recommends its drug for people with severe gastroparesis.

Kidney injury. Postmarketing reports tie most cases to dehydration from vomiting or diarrhea.

Low blood sugar. The risk goes up if you also take insulin or a sulfonylurea for type 2 diabetes.

Eye changes if you have diabetes. Zepbound’s label says diabetic retinopathy can temporarily worsen with rapid improvement in blood sugar control. In a two-year trial of semaglutide in people with type 2 diabetes, retinopathy complications occurred in 3% versus 1.8% on placebo. Both labels say people with a history of it should be monitored.

The labels also list allergic reactions and a small rise in resting heart rate. On Wegovy the average was 1 to 4 beats per minute.

Are There Long-Term GLP-1 Side Effects?

The long-term record is thinner than the first-months record. The trials I opened run a few years, not decades.

The longest was SELECT, published in the New England Journal of Medicine. It followed 17,604 adults age 45 and older who had heart disease and a BMI of 27 or higher but no diabetes. Average time on semaglutide 2.4 mg or placebo was about 34 months. In that time, 16.6% of the semaglutide group stopped treatment because of an adverse event, against 8.2% on placebo.

The same trial counted heart attacks, strokes and cardiovascular deaths: 6.5% on semaglutide versus 8.0% on placebo. The Wegovy label now covers cutting cardiovascular risk in adults with established cardiovascular disease and obesity or overweight. Weighing that against the side effects is a conversation for your prescriber.

Is Depression a Side Effect of GLP-1 Drugs?

This one gets searched a lot because the weight-loss labels used to carry a warning about suicidal thoughts and behavior. In January 2026 the FDA asked the makers to remove it from the Wegovy and Zepbound labels. I opened both current labels, and both list that section as removed in February 2026.

The FDA’s review included a pooled analysis of 91 placebo-controlled trials with 107,910 patients. It did not show an increased risk of suicidal thoughts or behavior, or of anxiety, depression, irritability or psychosis. The FDA’s notice still says to tell your health care professional about new or worsening depression or any unusual change in mood. If you’re in distress, call or text 988.

Are GLP-1 Side Effects Different for Older Adults and Men Over 50?

The side effect list is the same. What changes is the context around it. Four things stand out.

Your other medications. These drugs slow stomach emptying, which can change how pills you swallow get absorbed. The Zepbound label names drugs with a narrow safety margin, like warfarin, as ones to monitor. It also found low blood pressure more often in patients already taking blood pressure medication (2.2% versus 1.2%). Bring your full medication list to the prescriber, supplements included.

Dehydration. Vomiting or diarrhea drains fluid, and dehydration is what connects GI side effects to kidney problems. The Wegovy Medication Guide is plain about it: drink fluids. The labels also say to tell your surgeon or anesthesia team you’re on it before any procedure that uses anesthesia or deep sedation.

Your age bracket. Zepbound’s label reports no overall safety differences between patients 65 and older and younger adults, though only 0.5% of its pooled weight-loss patients were 75 or older. Wegovy’s label notes that in its cardiovascular trial, patients 75 and older reported more hip and pelvis fractures than on placebo.

Muscle. Not all the weight you lose is fat. In the STEP 1 body scan substudy, about 38% of the weight lost on semaglutide was lean mass. In the SURMOUNT-1 body scan substudy, about 25% of the weight lost on tirzepatide was lean mass. Lean mass isn’t all muscle, and the research on older adults is thin, as the review below says.

A 2026 narrative review of 21 studies adds some balance. Most found a loss of skeletal muscle mass that accounted for up to 8.5% to 24.5% of total weight loss, while strength generally didn’t change significantly. Only four of the 21 studies looked at older adults, which the authors say isn’t enough to tell whether age makes you more vulnerable.

If you haven’t started yet and you’re still sorting out whether it makes sense for you, start with GLP-1 for men over 50.

How Do You Manage GLP-1 Side Effects During Weight Loss?

Eating habits are where the expert consensus starts. A 2022 expert consensus in the Journal of Clinical Medicine (Gorgojo-Martínez and colleagues) laid out practical steps for each symptom:

• Nausea: eat slowly, eat smaller portions, stop when you feel full, and don’t lie down right after a meal.
• Vomiting: smaller, more frequent meals and careful hydration.
• Diarrhea: drink plenty, and cut back on coffee, alcohol and sugar-free sweeteners like sorbitol.
• Constipation: enough fiber, plenty of water, and more physical activity.

The dose side is the prescriber’s call, not yours. A 2024 review in Obesity Pillars notes that people who struggle may do better staying on a dose longer or stepping back down. If a symptom is wrecking your week, that’s the conversation to have.

Compounded versions sold through telehealth aren’t the products these trials tested. Compounded GLP-1s are not FDA-approved, and the FDA says salt forms such as semaglutide sodium and semaglutide acetate are different active ingredients from the ones in the approved drugs. The FDA also says it has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide. Our GobyMeds review covers what that route costs and how it works.

When Should You Call Your Doctor About GLP-1 Medication Side Effects?

Tell your prescriber about any of these. The Wegovy Medication Guide says to call right away for the first and third items, and to stop the medicine for severe stomach pain that won’t go away.

• Severe pain in your stomach area that will not go away, with or without vomiting, sometimes felt in your back. The Medication Guide says to stop the medicine and call your healthcare provider right away.
• Pain in your upper stomach, yellowing of the skin or eyes, fever, or clay-colored stools (possible gallbladder problems).
• Nausea, vomiting or diarrhea that doesn’t go away.
• A lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
• Signs of low blood sugar, such as shakiness, sweating, confusion or a fast heartbeat, if you have type 2 diabetes, especially if you also take insulin or a sulfonylurea.

For swelling of the face, lips, tongue or throat, or problems breathing or swallowing, stop the medicine and get medical help right away. Tell your prescriber too if your heart races or pounds at rest for several minutes. The FDA’s notice also says to tell your health care professional about new or worsening depression or any unusual change in mood.

If you’re ready to talk to a licensed provider about whether a GLP-1 fits, GobyMeds and ShedRX are the two services we cover. Either way, go in with your medication list and these questions.

Frequently Asked Questions

Which GLP-1 has the fewest side effects?

The labels don’t let anyone rank them honestly. Both say adverse reaction rates from one drug’s trials can’t be directly compared with another’s. Wegovy’s 44% nausea and Zepbound’s 25% to 29% came from separate trials, so the gap doesn’t prove one is gentler. Your prescriber can weigh your health history.

Can GLP-1 drugs cause hair loss?

Yes, both labels list it, and both tie it to weight reduction. It was reported by 0.9% of men on Wegovy and 0.5% of men on Zepbound.

Do side effects come back when the dose goes up?

They can. The Zepbound label says most nausea, vomiting and diarrhea happened during dose escalation. Whether to wait, step down or stay put is your prescriber’s decision.

Is constipation a common GLP-1 side effect?

Yes. It was reported in 24% of Wegovy patients versus 11% on placebo, and 11% to 17% of Zepbound patients versus 5%.

Do GLP-1 side effects get worse with age?

The labels don’t say that in general. Zepbound reports no overall safety differences at 65 and older. Wegovy’s label notes that adults 75 and older, on the drug or on placebo, reported more serious adverse reactions overall than younger adults.

Related Reading

• Wondering if a compounded shot carries the same risks? Compounded vs brand-name GLP-1 walks through what’s actually different.
• That 25% to 38% lean mass number is the one I’d lose sleep over. How to keep muscle on a GLP-1 after 50 covers what the evidence says about it.